Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
?

?

3.060%
0.15
3.060%
-

-

 
08:47 / Stuttgart Stock Exchange WKN: A2N9MM / Name: Marinomed Biotech / Stock / ? /

Marinomed Biotech AG Stock

Marinomed Biotech AG dominated the market today, gaining €0.15 (3.060%).
For the coming years our community has positive and negative things to say abot the Marinomed Biotech AG stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "Expected dividend yield" there were negative voices in the community.

Pros and Cons of Marinomed Biotech AG in the next few years

Pros
?
S********** s********
?
M***** P*******
?
B****
Cons
?
C******** o* t** e**********
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'

News

EQS-News: Marinomed Biotech AG seeks reorganisation through restructuring proceedings without self-administrationPhoto, wide shot, wide-angle lens,  Pharmaceutical company, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ae4a134-dd01-4c80-a621-18399f5a2541.png
EQS-News: Marinomed Biotech AG seeks reorganisation through restructuring proceedings without self-administration
EQS-News: Marinomed Biotech AG seeks reorganisation through restructuring proceedings without self-administration
EQS-Adhoc: Ad-hoc: Marinomed Biotech AG files for court restructuring proceedings without self-administrationPhoto, wide shot, wide-angle lens,  Biotech company, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Sebastião Salgado: https://img.theapi.app/temp/80e18bfd-1ff8-4487-af62-1cdb7de1ceb6.png
EQS-Adhoc: Ad-hoc: Marinomed Biotech AG files for court restructuring proceedings without self-administration
EQS-Adhoc: Ad-hoc: Marinomed Biotech AG files for court restructuring proceedings without self-administration
EQS-Adhoc: Ad-hoc: Marinomed Biotech AG plans to apply for court restructuring proceedings without self-administrationPhoto, wide shot, wide-angle lens,  Pharmaceutical company, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ae4a134-dd01-4c80-a621-18399f5a2541.png
EQS-Adhoc: Ad-hoc: Marinomed Biotech AG plans to apply for court restructuring proceedings without self-administration
EQS-Adhoc: Ad-hoc: Marinomed Biotech AG plans to apply for court restructuring proceedings without self-administration